Is brain fog in a patient taking Vraylar (cariprazine) due to the medication or tetrahydrocannabinol (THC) withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brain Fog: Distinguishing Vraylar vs THC Withdrawal as the Cause

Both Vraylar (cariprazine) and THC withdrawal can cause cognitive difficulties described as "brain fog," but the evidence strongly suggests THC withdrawal is the more likely culprit if you recently stopped cannabis use, while Vraylar's cognitive effects are typically mild and dose-dependent.

Understanding Each Contributor

THC Withdrawal and Cognitive Impairment

Cannabis withdrawal produces well-documented cognitive difficulties that patients describe as "brain fog." The American College of Physicians recognizes that cannabis withdrawal symptoms include irritability, insomnia, and headaches, though cognitive difficulties are not explicitly listed in the formal withdrawal criteria 1. However, research demonstrates that cognitive deficiencies from cannabis use "seem to persist after withdrawal" 2.

The timeline matters critically:

  • Withdrawal symptoms from THC typically begin within 24-48 hours of cessation and can persist for weeks 1
  • Cannabis use is associated with "difficulties in concentration and impairment of memory," and these cognitive deficiencies may continue during the withdrawal period 2
  • Long-term cannabis use causes neuropsychological decline, particularly affecting memory and concentration 1

Vraylar (Cariprazine) and Cognitive Effects

Vraylar's FDA label explicitly warns about "sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities" 3. The medication guide specifically states patients should "not drive, operate machinery, or do other dangerous activities until you know how VRAYLAR affects you" because it "may make you drowsy" 3.

Key characteristics of Vraylar-related cognitive effects:

  • Side effects may have delayed onset—they "may not happen right away and can start a few weeks after you start taking VRAYLAR, or if your dose increases" 3
  • The medication "stays in your body for a long time," meaning cognitive effects can persist 3
  • Common side effects include "sleepiness, feeling tired, trouble sleeping, and dizziness" 3
  • Research indicates cariprazine shows efficacy in animal models addressing cognitive symptoms of schizophrenia, suggesting it may actually improve rather than impair cognition in some contexts 4

Clinical Decision Algorithm

Step 1: Establish Timeline

  • If brain fog started within 1-7 days of stopping THC: Withdrawal is the primary suspect 1
  • If brain fog started 2-4 weeks after starting Vraylar or increasing the dose: Vraylar is more likely responsible 3
  • If both occurred simultaneously: Both may be contributing

Step 2: Characterize the Symptoms

THC withdrawal typically presents with:

  • Concentration difficulties and memory impairment 2
  • Irritability and insomnia (which worsen cognitive function) 1
  • Headaches 1
  • Anxiety 1

Vraylar-related cognitive effects typically present with:

  • Drowsiness and sedation as the predominant feature 3
  • Difficulty with motor skills and thinking 3
  • Feeling tired or weak 3
  • Dizziness 3

Step 3: Assess Severity and Functional Impact

  • If the brain fog is severe enough to impair daily functioning and you recently stopped cannabis after regular use (especially if used 4+ times per week for over a year): THC withdrawal is highly likely 1
  • If drowsiness and sedation are the primary complaints rather than concentration/memory problems: Vraylar is more likely 3

Management Approach

If THC Withdrawal is Suspected:

The cognitive difficulties from cannabis withdrawal typically resolve over weeks to months 1. Management focuses on:

  • Supportive care and reassurance that symptoms will improve
  • Addressing concurrent withdrawal symptoms (insomnia, irritability, anxiety) that may worsen cognitive function 1
  • Avoiding return to cannabis use, as this perpetuates the cycle

If Vraylar is Suspected:

Discuss with your prescriber whether:

  • The dose can be reduced (cognitive effects may be dose-dependent) 3
  • The timing of administration can be adjusted (taking at bedtime may minimize daytime cognitive impact)
  • The benefits of Vraylar for your psychiatric condition outweigh the cognitive side effects 3

Critical safety note: Never stop Vraylar abruptly without medical supervision, as your underlying psychiatric condition requires ongoing treatment 3.

Important Caveats

  • Both substances can cause cognitive difficulties simultaneously—this is not an either/or situation 3, 2
  • Brain fog is a lay term describing subjective cognitive difficulties that can result from neuroinflammation, poor sleep, medications, or substance withdrawal 5
  • If brain fog persists beyond 4-6 weeks or worsens, other causes must be considered, including depression, anxiety, sleep disorders, or other medical conditions 5
  • The majority of high-quality evidence suggests that cannabis-based medicines with low to moderate THC doses have only minor negative impacts on cognitive functioning, but long-term use may adversely affect cognition 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The effects of cannabinoids on the brain.

Progress in neurobiology, 1999

Research

Cariprazine:New dopamine biased agonist for neuropsychiatric disorders.

Drugs of today (Barcelona, Spain : 1998), 2016

Research

Brain Fog: A Bit of Clarity Regarding Etiology, Prognosis, and Treatment.

Journal of psychosocial nursing and mental health services, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.